Table 3:

Baseline characteristics of atherosclerotic-related occlusion before and after matchinga

Before MatchingPAfter MatchingP
ST 6 (n = 95)ST 4 (n = 171)ST 6 (n = 66)ST 4 (n = 66)
Age (mean) (SD) (yr)65 (11)63 (13).08664 (11.4)62 (11.7).249
Women (No.) (%)28 (29.5%)47 (27.5%).73016 (24.2%)16 (24.2%)1.000
Hypertension (No.) (%)65 (68.4%)115 (67.3%).84548 (72.7%)42 (63.6%).307
Diabetes mellitus (No.) (%)21 (22.1%)30 (17.5%).36516 (24.2%)7 (10.6%).078
Current smoker (No.) (%)34 (35.8%)56 (32.7%).61525 (37.9%)25 (37.9%)1.000
SBP (median) (IQR) (mm Hg)148 (135–163)147 (130–160).351148 (135–162)140 (129–160).268
GLU (median) (IQR) (mmol/L)6.54 (5.46–9.00)6.70 (5.68–8.32).8126.41 (5.2–8.95)6.62 (5.7–8.34).538
ASPECTS (median) (IQR)9 (7–10)9 (8–10).0129 (8–10)10 (8–10).233
NIHSS (median) (IQR)16 (12–20)16 (11–19).15416 (12–19)16 (11–19).873
IV (No.) (%)30 (31.6%)61 (35.7%).50025 (37.9%)24 (36.4%)1.000
Time from onset to visit (median) (IQR) (min)153 (90–232)120 (60–216).032152 (90–220)122 (49–242).450
Time from onset to treatment (median) (IQR) (min)293 (225–364)280 (210–356).352289 (224–351)275 (206–355).532
Artery occlusion site
    ICA (No.) (%)55 (57.9%)33 (19.3%)<.00132 (48.5%)29 (43.9%).375
    MCA (No.) (%)39 (41.1%)136 (79.5%)<.00133 (50%)36 (54.5%).375
    ACA (No.) (%)1 (1.1%)2 (1.2%).9311 (1.5%)1 (1.5%)1.000
Collateral flow grade (ASITN/SIR).0231.000
    0–1 (No.) (%)50 (52.6%)65 (38.2%)32 (48.5%)31 (47%)
    2–3 (No.) (%)45 (47.4%)105 (61.8%)99 (51.5%)214 (53%)
  • Note:—ASITN/SIR indicates American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology; GLU, glucose; ACA, anterior cerebral artery; SBP, systolic blood pressure.

  • a The logistic regression model used for the determination of the propensity score included the following factors: age, time from onset symptom to visit, time from onset to groin puncture, NIHSS score, ASPECTS, site of vessel occlusion, and collateral blood flow.